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In most animals, advancing age is accompanied by the 
deteriorative process of aging (senescence). Aging is the 
main cause of severe illness and death in humans, but 
the proximate biological mechanisms that cause it have 
proved difficult to identify. One approach to understand 
aging is to study simple model organisms [1], such as 
the nematode Caenorhabditis elegans which is 
particularly suitable for this purpose given e.g. its 
sequenced genome and very short lifespan (2-3 weeks).  
The identification from the 1980s onwards of many C. 
elegans mutants with altered aging rate [1] led to 
optimism that discovery of gene products of aging 
control genes would reveal the mechanisms of aging in 
this organism.  Yet  although  many signaling  pathways  
 
 





































and processes affecting aging rate have been identified, 
the nature of aging itself has remained obscure. For 
example, mutation of the daf-2 insulin/IGF-1 receptor 
gene can more than double adult lifespan [2]. This 
increase requires the presence of the DAF-16 FoxO 
transcription factor [2-4], suggesting that transcriptional 
targets of DAF-16 encode proximal biochemical 
determinants of aging. But these target genes have 
proved to be very numerous [5, 6], 2,274 by one 
estimate [7], complicating the search for DAF-16 target 
genes that control aging. Understanding DAF-16/FoxO 
action is important, particularly because the role of 
insulin/IGF-1 signaling and FoxO in the control of 
aging shows evolutionary conservation, e.g. in the 
fruitfly Drosophila [8], and perhaps even in humans, 





















MDL‐1 Mad basic helix‐loop‐helix  leucine  zipper  transcription  factor. Here we describe  the  role of mdl‐1  in C.  elegans
germline proliferation and aging. The deletion allele mdl‐1(tm311) shortened lifespan, and did so significantly more so in
long‐lived daf‐2 mutants implying that mdl‐1(+) contributes to effects of daf‐2 on lifespan. mdl‐1 mutant hermaphrodites
also  lay  increased numbers of unfertilized oocytes. During aging, unfertilized oocytes  in the uterus develop  into tumors,
whose development was accelerated by mdl‐1(tm311). Opposite phenotypes were seen  in daf‐2 mutants,  i.e. mdl‐1 and
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where age changes in allele frequency e.g. of the IGF-1 
receptor and FoxO3A genes have been detected [1].  
 
One approach to understand DAF-16 action is to map 
the gene regulatory network in which it acts. Previously 
we used a genome-wide approach to identify genes to 
which DAF-16 both binds and causes a change in gene 
expression [9]. This identified a mere 65 high 
confidence DAF-16 direct targets, which were enriched 
for genes encoding proteins involved in signaling and 
gene regulation, and transcription factors. Among the 
latter class was mdl-1 (Mad-like 1), which encodes a 
basic helix-loop-helix (bHLH) TF homologous to 
mammalian Mad transcription factors [10] (Figure 1A). 
In mammals, Mad TFs act as heterodimers with Max 
bHLH TFs. Mad competes with Myc bHLH TFs to 
dimerize with Max, and bind to target genes containing 
E-box sequences (5’-CANNTG-3’) [11]. Myc/Max 
dimers mainly activate gene expression, and are a major 
activator of cell proliferation of growth. By contrast, 
Mad/Max dimers mainly inhibit gene expression, 
antagonizing Myc/Max, and suppressing cell division 
and growth [11]. Inhibition of gene expression by 
Mad/Max is facilitated by recruitment of the Sin3 
histone deacetylase (HDAC) corepressor complex. Myc 
TFs are potent oncogenes, while Mad TFs show some 
properties of tumor suppressors [11].  
 
Our attention was drawn to mdl-1 for several reasons. 
First, many genes that promote growth also promote 
aging [12]. Thus, growth suppressors activated by DAF-
16 are candidates for downstream effectors slowing 
aging, and MDL-1, as a Mad TF, is a potential growth 
suppressor and, in fact, can suppress activated 
cMyc/Ras-induced cell transformation in mammalian 
cells [10]. Second, four mammalian Mad TFs, mad1, 
mxi1, mad3 and mad4, are up-regulated by FoxO3a in a 
human colorectal adenocarcinoma cell line [13]. Thus, 
regulatory interactions between FoxO and Mad show at 
least some evolutionarily conservation between 
nematodes and mammals. Consistent with this, in C. 
elegans mdl-1 is an activator of intestinal expression of 
ftn-1 (H ferritin, an iron storage protein) [14], while in 
mammals, Myc can repress H ferritin expression, which 
contributes to cell proliferation [15].  
 
C. elegans possesses several Max-like (mxl) genes, 
including mxl-1 which can form heterodimers with 
MDL-1 but, surprisingly, lacks Myc [10, 16, 17]. 
Previous RNAi screens have not detected major effects 
of expression knockdown of mdl-1 or mxl-1 
(Wormbase.org). However, mdl-1 exerts some influence 
upon the germline, as follows. Loss of daf-2 inhibits 
lethal, gld-1-induced distal germline tumors via 
decreased cell division and increased DAF-16/p53-
dependent apoptosis [18], and mdl-1 is a mediator of 
this inhibition [19]. Moreover, RNAi of mdl-1 can 
reduce daf-2 mutant longevity, but has little effect on 
lifespan in daf-2(+) worms [6].  
 
In this study, we explore the possible role of mdl-1 as a 
downstream effector of DAF-16 in the control of aging. 
In particular, we detail the phenotypic effects of 
mutation of mdl-1. We report that mdl-1 acts as a 
repressor of germline hyperplasia and hypertrophy 
which otherwise contributes to age-related pathology in 




mdl-1(tm311) increases production of unfertilized 
oocytes 
 
To investigate mdl-1 gene function, we studied the mdl-
1(tm311) mutant allele, which contains a 471 bp base 
pair deletion that removes exon 2 of the gene (Figure 
1A). This results in a frame shift after 51/281 amino 
acid residues and loss of the entire bHLH domain, 
implying that this is a null allele. The mutation was first 
backcrossed 6x into the Caenorhabditis Genetics Center 
wild type male stock to remove possible second site 
mutations, and ensure a wild type background [20]. 
Previous work on mdl-1 and the function of Mad TFs in 
mammals led to several expectations about the possible 
effects of mdl-1(0). First, since it is a DAF-16-activated 
gene, it might suppress daf-2 mutant traits, e.g. 
constitutive dauer larva formation (Daf-c), stress 
resistance and increased longevity (Age). Second, since 
Mad TFs inhibit cell division and growth, mdl-1(0) 
might increase either somatic growth or germline 
proliferation.  
 
We first examined effects of mdl-1(0) on somatic 
development and growth in wild type and daf-2 mutant 
backgrounds. mdl-1(0) had no detectable effect on 
larval or adult growth (Figure 1B), but caused a slight 
reduction in constitutive dauer formation in daf-
2(m577) mutants (Figure 1C). Next we probed the 
effects of mdl-1 on the germline, first by looking at 
levels of fertility. The number of progeny produced by 
self-fertilized hermaphrodites was not affected by mdl-
1(0), either in terms of overall brood size or 
reproductive schedule (Figure 1D,E). As self sperm 
becomes depleted, N2 hermaphrodites start laying 
unfertilized oocytes [21]. Notably, mdl-1(0) caused a 
marked increase in the number of unfertilized oocytes 
laid, from 121 ± 15 to 219 ± 30, an 81% increase 
(Figure 1D). mdl-1(RNAi) applied to RNAi-sensitive 
rrf-3(pk1426) mutants also increased unfertilized oocyte 
number (data not shown).  
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In daf-2(m577) mutants, progeny number was also not 
different to N2, but the number of unfertilized oocytes 
laid was significantly reduced (Figure 1D,E), consistent 
with previous findings [22]. For convenience, to 



















































Uno (abnormal in unfertilized oocyte production), and 
Uno-o, to describe mutants that are unfertilized oocyte 
over-producers (e.g. mdl-1), and Uno-d, to describe 

























































Effect of mdl‐1 and daf‐2 on  fertility. Number of broods scored: N2, 19; daf‐2, 20; mdl‐1, 17.  (D) Mean  total progeny and unfertilized
oocytes. * 0.01 < p < 0.05, *** p < 0.001 (Student’s t test). (E) Mean daily progeny and unfertilized oocyte numbers.  
  














































































































Figure  2. mdl‐1  causes  hyperplasia  and  hypertrophy.  (A,  B) mdl‐1(0)  causes  oocyte  stacking  in  1  day  old worms.  (A)
Nomarski images. (B) Quantitation of stacking. Sample sizes: N2, 23; mdl‐1, 17. *** p < 0.001 (Student’s t test). (C) No effect of
mdl‐1  on  number  of  germline  nuclei.  p  >  0.05  (Student’s  t  test).  (D,  E)  mdl‐1  increases  levels  of  germline  apoptosis.  (D)
Epifluorescence images of SYTO12 stained cells in young adult hermaphrodite germline. (E) Quantitated data. Number of gonads
scored: N2, 153; mdl‐1, 132. *** p < 0.001 (Student’s t test). (F, G) mdl‐1 increases cytoplasmic streaming in the proximal gonad.
(F) Single  image obtained  from a  time‐lapse  recording. Arrows  represent DIC‐particle  tracks. DIC‐particles were  tracked over a
period of 1 minute. Scale bar: 20 µm. (G) Cytoplasmic streaming rate (mean particle speed ± standard error). 30 particle speed
measurements performed for each genotype. Number of worms examined: N2, 4; mdl‐1, 3. *** p < 0.001 (Student’s t test). (H)
Absence  of  effect  of mdl‐1(0)  on  gonad  disintegration  (25˚C).  p  >  0.05  for  all  comparisons  of N2  vs. mdl‐1  of  the  same  age
(Wilcoxon Mann test). (I) Uterine status scale for quantitation of uterine tumor formation rate (5 classes). Class 1, normal uterus




www.impactaging.com                    101                                     AGING, February 2014, Vol. 6 No.2
mdl-1(tm311) causes germline hyperplasia and 
hypertrophy 
 
The mdl-1 Uno-o phenotype suggests increased cell 
production in the germline distal to the spermatheca. To 
test this we compared proximal gonad contents in wild 
type and mdl-1 animals on day 1 of adulthood. This 
revealed increased oocyte density, or stacking [23, 24], 
in mdl-1 (Figure 2A,B), implying increased oocyte 
synthesis. This in turn suggests increased germ cell 
proliferation in the distal gonad.  To probe this, we 
examined germ cell number by staining nuclei with the 
fluorescent DNA-binding dye 4',6-diamidino-2-
phenylindole (DAPI), but no effect of mdl-1 was 
detected (Figure 2C). However, an increase in the 
overall rate of germline cell turnover in mdl-1 mutants 
could leave cell number unaffected.  
 
If the distal proliferative zone is the source of germ cell 
nuclei, then the major sink is germline apoptosis. At 
least 50% [25] and as many as 97% [26] of germ cells 
undergo p53-independent, “physiological” apoptosis, 
their cytoplasm supplying expanding oocytes near the 
gonad bend. Using the SYTO 12 dye to detect apoptotic 
cell corpses, we found that mdl-1 mutants showed a 
significant increase in apoptotic cell number in the 
germline in 3 out of 4 trials (Figure 2D, E).  
 
The transfer of cytoplasm released by germ cells to 
nascent oocytes occurs by a process of cytoplasmic 
streaming (Figure 2F) [27]. We examined the effect of 
mdl-1(0) on the rate of cytoplasmic streaming in the 
mid-late pachytene region of the distal gonad, on day 1 
of adulthood. Cytoplasmic streaming rate in mdl-1 
worms was significantly greater than in wild type 
(Figure 2G). Taken together, these results suggest that 
an increase in production of germ cells is matched by an 
increase in apoptosis, resulting in little change in overall 
germ cell number in the distal arm. Overall, this 
suggests that the increase in oocyte production is driven 
by a hyperplastic state in the distal gonad.  
 
Next we studied the effect of mdl-1 on pathologies of 
aging in the germline. The aging hermaphrodite gonad 
undergoes dramatic pathological changes. The distal 
gonad shrivels and eventually disintegrates [28, 29], 
while in the uterus large, amorphous masses (tumors) 
with very high DNA content develop [24, 29-31]. These 
tumors form from unfertilized oocytes which undergo 
multiple rounds of endoreduplication, and can grow to 
fill the entire body cavity in the mid-body. Continued 
germline apoptosis in late life contributes to gonad 
disintegration, and increased apoptosis rate is sufficient 
to increase gonad disintegration rate (Y. de la Guardia 
and D. Gems, unpublished). However, despite their 
increased apoptosis rate (Figure 2D,E) gonad 
disintegration rate was not detectably altered in mdl-1 
mutants (Figure 2H).  
 
Casual observation of mdl-1 hermaphrodites under 
Nomarski microscopy suggested an increase in uterine 
tumors in these mutants. To verify this, we used a semi-
quantitative approach [28] with a uterine status scale. 
According to the appearance of the uterus, worms were 
scored from 1 (healthy, no tumors) to 5 (large tumors) 
(Figure 2I) (see Materials and Methods). Using this 
scale to compare N2 and mdl-1 mutants confirmed that 
uterine tumors grow significantly faster in mdl-1 worms 
(Figure 2J).  
 
mdl-1 does not mediate effects of daf-2 on germline 
proliferative status 
 
We next investigated whether MDL-1, like DAF-16, is 
an effector of daf-2 mutant phenotypes. We first 
verified that DAF-16 acts directly on mdl-1 to increase 
its expression, as predicted by mRNA and chromatin 
profiling studies [9]. Quantitative RT-PCR confirmed 
that mdl-1 mRNA levels are higher in daf-2 than in daf-
16; daf-2 strains (Figure 3A). Chromatin immuno-
precipitation and PCR (ChIP-PCR) confirmed that 
DAF-16 binds to the mdl-1 promoter (Figure 3B). This 
implies that mdl-1 expression is activated by DAF-16 
binding to its promoter.  
 
mdl-1 mutants are Uno-o while daf-2 mutants are Uno-
d (Figure 1D,E) [22], and DAF-16 activates mdl-1 
expression (Figure 3A,B) [9]. This could imply that 
increased mdl-1 activity in daf-2 mutants reduces 
oocyte production. To test this we asked whether mdl-
1(tm311) would suppress daf-2 Uno-d, but it did not. 
Instead, daf-2(m577); mdl-1 worms were Uno-d 
(Figure 3C), i.e. daf-2 is epistatic to mdl-1. daf-
2(m577) also suppressed mdl-1 effects on oocyte 
stacking and uterine tumor formation (data not shown). 
These results negate our hypothesis that daf-2 Uno-d is 
caused by mdl-1 over-activity. A different model was 
suggested by additional epistasis data as follows. In a 
daf-2(+) background, daf-16 suppressed mdl-1 Uno-o, 
consistent with the observation that daf-16 over-
expression in a daf-2(+) background can cause 
germline hyperplasia [32]. Thus, DAF-16 promotes 
oocyte production in a daf-2(+) background but 
inhibits it in a daf-2(m577) background (Figure 3D). 
Moreover, mutation of daf-16 in a daf-2; mdl-1 mutant 
did not restore MDL-1 Uno-o (Figure 3C). This 
suggests that MDL-1 suppresses the effect of DAF-16 
on oocyte production in daf-2(+) worms, but plays no 
role in daf-2 mutants (Figure 3D).  
  
















































































































0.001  <  p  <  0.01.  (B)  DAF‐16  binds  to  the mdl‐1  promoter  (ChIP‐PCR  data). One  experiment  is  shown which  contained  3
immuno‐precipitation replicates from the same chromatin preparation (error bars show the standard deviation between them).
The dotted  line shows the average  inputs from 3 genes/genomic regions that do not show enrichment for DAF‐16 binding  in
daf‐2 vs daf‐16; daf‐2  in  this particular  trial,  i.e.  it reflects background DAF‐16 binding  levels. Significant DAF‐16 binding was
detected one of two additional trials. The position of the DAF‐16 binding site detected is shown in Figure 1A. (C) mdl‐1, daf‐2
and daf‐16 epistasis analysis with  respect  to unfertilized oocytes production  (Uno). Total unfertilized oocyte production per
worm was measured at 25˚C. Means of 12 broods assessed; error bars,  standard error. ** 0.001 < p < 0.01; *** p < 0.001
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daf-2 mutants exhibit various forms of stress resistance, 
including oxidative stress resistance (Oxr) [33]. We 
tested whether MDL-1 contributes to daf-2 Oxr, 
specifically to tert-butylhydroperoxide (t-BOOH). In a 
wild-type background, mdl-1(0) did not affect Oxr, 
while daf-2(m577) markedly increased Oxr (Figure 3E). 
Notably, in a daf-2(m577) background, mdl-1(0) 
significantly decreased Oxr. This implies that MDL-1 
contributes to daf-2 Oxr.  
 
MDL-1 contributes to daf-2 mutant longevity by 
reducing baseline hazard 
 
Next, we examined the effect of mdl-1 on aging. First 
we compared effects of mdl-1(RNAi) on lifespan in rrf-
3 and rrf-3; daf-2(e1368) strains (25˚C), and detected a 
reduction in lifespan only in the latter strain (data not 
shown), consistent with previous observations [6]. We 
then assessed the effect of mdl-1(tm311) on lifespan in 
wild-type or daf-2(m577) mutant backgrounds. mdl-1 
decreased lifespan in both wild-type and daf-2 
backgrounds, but the decrease was proportionally 
greater in the latter (Figure 4A, Table S1). This 
corresponded to a significantly greater mdl-1-induced 
increase in mortality in a daf-2 background (4.5-fold vs 
1.8-fold; significant interaction term, p < 10-15, Cox 
proportional hazard analysis), suggesting that mdl-1 
activity contributes to the daf-2 longevity increase. 
 
To further characterize the effect of mdl-1 on aging, we 
examined its effect on the pattern of age-specific 























Aging animal populations typically show exponential 
increases in mortality rate, and in C. elegans this occurs 
in two stages, with an initial faster exponential increase 
and a subsequent slower exponential increase [34, 35]. 
We fitted mortality data to a logistic model, which 
contains 3 components: a baseline hazard (initial 
mortality rate, parameter a), a mortality increase rate 
(parameter b) and a late-life mortality deceleration 
(parameter s).  
 
In this analysis we wanted to probe whether mdl-
1(tm311) shortens lifespan by accelerating aging or 
whether it could act by a life-shortening effect unrelated 
to aging. An effect of mdl-1 on parameters b and s 
would imply an effect on aging, whereas an effect on 
parameter a could imply a non-aging related deleterious 
effect. In fact, mdl-1 increased baseline hazard (a) 
without affecting the mortality increase rate (b) (Figure 
4B-D). By contrast, relative to wild type, daf-2(m577) 
markedly decreased parameters b and s, while also 
slightly increasing parameter a. Reducing insulin/IGF-1 
signaling has long been known to slow the age-related 
mortality rate increase [36]. In a daf-2 background, mdl-
1(0) again increased baseline hazard, and had no 
significant effect on parameters b and s (p > 0.05) 
(Figure 4C,D). In summary, this analysis confirms that 
daf-2 increases lifespan by slowing demographic aging, 
while mdl-1 shortens lifespan mainly by increasing 
baseline hazard. That mdl-1 shortens lifespan more in a 
daf-2 background could imply that MDL-1 contributes 


























Effect of mdl‐1 on age‐specific mortality profiles.  (C, D) Mortality analysis using  logistic model.  (C) Estimated values of  logistic
model parameters. (D) Probability, p, of parameters in compared genotypes being the same, holding other parameters constant. 
  















































Uterine tumors do not limit lifespan 
 
mdl-1(0) accelerates formation of uterine tumors, which 
frequently grow very large, filling the body cavity in the 
mid-body region and squashing the intestine [31]. One 
possibility is that uterine tumors can contribute to 
mortality and that increased tumor formation in mdl-
1(0) mutants causes a shortened lifespan. To test this, 















































absence of uterine tumors. glp-4(bn2) mutants have a 
temperature-sensitive germline proliferation defect; if 
raised at 15˚C to L4 and then switched to 25˚C, oocyte 
production is blocked but longevity is not increased [7]. 
We first confirmed that glp-4 blocks formation of 
uterine tumors (Figure 5A). We then compared lifespan 
in glp-4, mdl-1 and glp-4; mdl-1 worms. glp-4 worms 
were normal-lived, but both mdl-1 strains were similarly 
short lived (Figure 5B; Table S2).  
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We also blocked uterine tumor formation using the 
inhibitor of DNA replication 5-fluoro-deoxyuridine 
(FUdR), which is also commonly used to treat 
colorectal cancer. Application of FUdR at low 
concentrations (e.g. 10-25μM) from L4 stage is a 
convenient means to block progeny production, and has 
little effect on lifespan [37]. 50μM FUdR, but not lower 
FUdR concentrations, was sufficient to block formation 
of uterine tumors (Figure 5C). We then compared 
effects of 50μM FUdR on lifespan in wild type and mdl-
1 worms, and saw no effect on lifespan in either case 
(Figure 5D; Table S2). These results show that 
accelerated formation of uterine tumors do not cause the 
shorter lifespan of mdl-1 worms. They also demonstrate 
that uterine tumors do not limit lifespan in wild type 
worms under standard culture conditions. This contrasts 
with the case of daf-16 over-expression, where life 
shortening is suppressed by blocking germline 
hyperplasia either with glp-1 or FUdR [32]. 
 
A number of interventions that remove the 
hermaphrodite germline cause increased lifespan, 
including raising glp-4(bn2) mutants at 25˚C, and this 
effect is daf-16 dependent [38, 39]. Notably, mdl-1(0) 
also reduced the longevity of glp-4 mutants raised at 
25˚C (Figure 5E, Table S2). mdl-1 shortened lifespan 
more in a glp-4 background than in a wild-type 
background (Table S2). This suggests that mdl-1(+) 
contributes to glp-4 longevity as well as daf-2 
longevity. 
 
Evidence that mdl-1 can act in the intestine to 
promote longevity 
 
The intestine plays an important role in daf-2 mutant 
longevity [40], and is a site of mdl-1 expression [10]. 
One possibility is that mdl-1 affects intestinal protein 
synthesis. Mutation of daf-2 causes a global reduction 
in protein synthesis, which may contribute to longevity 
[41, 42]. In aging hermaphrodites, yolk proteins 
(vitellogenins) become very abundant indeed [43, 44], 
and this accumulation is suppressed daf-2, apparently 
by inhibition of protein translation in the intestine [45] 
where yolk is synthesized [46]. Thus, vitellogenin 
accumulation rate gives some indication of intestinal 
protein synthesis rate. However, mdl-1(0) did not alter 
vitellogenin accumulation, either in wild type or daf-2 
mutant backgrounds (Figure 6A,B). One possibility is 
that mdl-1 mutants do synthesize more vitellogenin, but 
due to increased laying of unfertilized oocytes, this does 
not result in increased vitellogenin accumulation. To 
check this we compared sterile glp-4 and glp-4; mdl-1 
worms (shifted at L4 to 25˚C), but again no effect of 
mdl-1 was seen (Figure 6A,B).  
 
Next, we asked whether intestine-limited rescue of mdl-
1 using the ges-1 promoter [47] would rescue mdl-1 
shortevity. A transgene array from which mdl-1 was 
expressed using its own promoter was able to restore 
wild-type lifespan to mdl-1(tm311) mutants (Figure 6C; 
Table S3). Notably, pges-1::mdl-1 too increased 
lifespan in mdl-1 mutants, though the effect was smaller 
such that lifespan was not restored to wild type. This 
suggests short lifespan in mdl-1 mutants is caused by 
loss of mdl-1 from several sites, including the intestine. 
Possibly, a second site of action of mdl-1 on lifespan is 
the germline, given its impact on that tissue. 
 
The extent of loss of Myc among nematodes 
 
One puzzle relating to mdl-1 function is the absence of 
Myc in C. elegans. In mammals, the Mad/Max/Myc 
system works in concert with the Tor pathways to control 
growth [48]. C. elegans also lacks key components of the 
Tor pathway, including the Tsc1/Tsc2 complex [49], and 
4E-BP [50] (Figure 7A). To try to understand the 
significance of the absence of Myc in the broader context 
of nematode gene loss, we tested for the presence of 
Myc, Tsc1, Tsc2 and 4E-BP throughout the Nematoda. It 
was previously noted that Myc orthologs are absent not 
only from C. elegans and C. briggsae, but also the filarial 
parasite Brugia malayi (nematode order Spirurida), and 
even the bilharzia parasite Schistosoma mansoni (phylum 
Platyhelminth) [51]. Searching the genomes of 13 
nematode species, including representatives of the major 
nematode orders, no Myc orthologs were detected 
(Figure 7B). Myc was also absent from all 5 
platyhelminth species examined. This implies that Myc 
evolved in the common ancestor of arthropods and 
chordates after divergence from the common ancestor of 
nematodes and platyhelminths, as previously suggested 
[51]. Thus, the Myc-less Mad-Max circuit in C. elegans 
appears to represent a more ancient regulatory system.  
 
By contrast, both Tsc1/Tsc2 and 4E-BP were found in 
several nematode groups but were absent from many 
others, in a pattern indicating that each gene has been lost 
several times during nematode evolution. For Tsc1 and 
Tsc2, gene loss was correlated, i.e. both genes were either 
present or absent. There was no correlation between loss 
of Tsc/Tsc2 and 4E-BP: nematode species exist with 
Tsc1/Tsc2 but lacking 4E-BP and vice versa. The 
distribution of Tsc1/Tsc2 is surprising in that most 
nematode and all platyhelminth groups lack this complex, 
apart from spirurid nematodes, and two rhabditid species. 
Sequence comparisons of Tsc1 and Tsc2 protein 
sequences from nematodes and other animal groups is 
consistent with multiple instances of gene loss (rather 
than horizontal gene transfer) (Figure 7C). 
 
  






















































































































































In this study we have shown that MDL-1 acts as an 
inhibitor of germline proliferation, and of oocyte 
hypertrophy, thereby inhibiting a salient aging-related 
pathology (uterine tumors). These properties of mdl-1 
mutants recapitulate effects of Mad TFs in mammals, 
e.g. mice lacking the Mad TF Mxi1 show hyperplasia in 
a number of tissues (e.g. prostatic epithelium), and are 
tumor prone [52]. We also confirm that MDL-1 inhibits 
aging, consistent with the observed association between 












































Does mdl-1 act downstream of daf-16? 
 
Our initial hypothesis was that activation of mdl-1 
expression by DAF-16 contributes to daf-2 longevity. 
The results of analysis of mdl-1 expression (Figure 
3A,B) and the effects on lifespan of mdl-1(tm311) 
(Figure 4A) are consistent with this hypothesis. We also 
noted that mdl-1 and daf-2 have opposing effects on the 
germline: mdl-1(0) causes Uno-o, increased oocyte 
stacking and increased uterine tumors (this study), while 
mutation of daf-2 has opposite effects [22, 29]. This 
suggested that the effects of daf-2 on the germline 
Figure 7. Extent of  loss of Myc, Tsc1/Tsc2 and 4E‐BP among the Nematoda. (A) Outline of missing





contortus  and  only  contigs  available  for  T. muris.  (C)  Phylodendrograms  of  Tsc1  and  Tsc2  sequences  for
nematodes and other animal groups. Note that species and sequence phylogenies correspond. 
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might be mediated by mdl-1. However, epistasis 
analysis shows that this is not the case for oocyte 
production (Figure 3C). Instead mdl-1 appears to have 
no effect on the germline in daf-2 mutants, but to inhibit 
promotion of germline proliferation by DAF-16 in daf-
2(+) worms (Figure 3D).  
 
Does mdl-1 affect aging? 
 
The life-shortening effect of mdl-1(0) is mainly the 
result of increased base-line hazard (Figure 4B-D). This 
could imply that mdl-1(0) does not affect aging but, 
rather, shortens lifespan by causing a pathology that is 
distinct from aging. In similar fashion, a comparison of 
mortality in two groups of people during the 1940s, 
either in Australia or interned by the Japanese, showed 
increased base-line hazard but not increased 
demographic aging in the latter [55]. It is interesting to 
consider whether this necessarily means that the effect 
of mdl-1 on lifespan does not involve an effect on 
aging. The impact of mdl-1(0) on lifespan is greater in a 
daf-2 background, suggesting that MDL-1 does 
contribute to daf-2 longevity, i.e. that mdl-1 does affect 
aging. Arguably, the critical point here is that something 
that affects demographic aging necessarily affects 
biological aging, while something that affects base-line 
hazard may or may not affect biological aging. In other 
words, the biological process of aging is not always the 
same thing as demographic aging.  
 
One working definition of biological aging is the set of 
endogenously generated pathologies that increase in 
later life [56]. In principle, interventions that reduce one 
or more age-related pathology (i.e. part or all of aging) 
could increase lifespan by reducing base-line hazard, 
demographic aging, or both. One possibility is that the 
wider the spectrum of age-related pathologies that an 
intervention suppresses, the more likely will a reduction 
in demographic aging be seen. In conclusion, mdl-1(0) 
may or may not affect aging. Its greater effect on daf-2 
could imply that it does; however, an alternative 
possibility is that mdl-1(0) causes a pathology that is 
distinct from those seen during aging, and that daf-2(-) 
slightly increases the severity of this pathology, or 
increases its effect on mortality.  
 
Where and how does mdl-1 act to impact lifespan? 
 
The phenotype of mdl-1(tm311) mutants demonstrates 
that MDL-1 acts as a repressor of growth and 
proliferation in the germline. This is consistent with the 
role of Mad TFs as repressors of growth and proliferation 
in mammals [11]. A long-standing hypothesis about 
aging is that it is caused by molecular damage, but more 
recently it has been suggested that aging is caused by the 
run on of developmental and reproductive processes in 
late life, leading e.g. to pathological hyperplasia, 
hypertrophy and atrophy [57-59]. The action of MDL-1 
as a DAF-16-activated suppressor of growth is broadly 
consistent with this model.  
 
The mdl-1 mutant phenotype also suggests that this 
gene may affect lifespan through its effects on the 
germline. One possibility is that over-production of 
oocytes or increased formation of uterine tumors per se 
cause a decrease in lifespan. However, our findings 
argue against this: suppression of these effects in mdl-1 
mutants using glp-4 or FUdR does not suppress the life-
shortening effects of mdl-1(0) (Figure 5B,D).  A second 
possibility is that mdl-1(0) affects signaling from the 
germline; removal of the germline can extend lifespan, 
and this effect is daf-16 dependent [39]. Consistent with 
this possibility, mdl-1(0) shortens lifespan somewhat 
more in long-lived germlineless glp-4 mutants than in 
otherwise wild-type worms (Figure 5E).  
 
Another possible site of mdl-1 action on lifespan is the 
intestine, which plays a significant role in the control of 
aging [40], and where mdl-1 is expressed [10]. Notably, 
intestine-limited rescue of mdl-1(+) in otherwise mdl-
1(0) worms was sufficient to modestly increase lifespan. 
However, how mdl-1 acts in the intestine remains 
unclear. Mutation of daf-2 increases intestinal 
expression of ftn-1, which encodes the iron storage 
protein ferritin. This increase is wholly daf-16 
dependent and partially mdl-1 dependent [14]. Free iron 
is required for growth (e.g. ferroprotein synthesis) but 
also generates oxidative stress. Thus, increased activity 
of MDL-1 in daf-2 mutants might retard intestinal aging 
as part of a program of suppression of protein 
biosynthesis. However, we did not detect an effect of 
mdl-1 on accumulation of the most abundant protein 
class in C. elegans hermaphrodites, the vitellogenins 
(Figure 6A,B), which are synthesized in the intestine 
[46]. However, it remains possible that other aspects of 
protein synthesis are reduced by mdl-1.  
 
Alternatively, mutation of mdl-1 might increase levels 
of free iron in the intestine, perhaps accelerating aging 
by increasing oxidative damage, as suggested by the 
free radical theory. Consistent with this, mdl-1(0) 
partially suppress daf-2 Oxr (Figure 3E), suggesting that 
MDL-1 promotes Oxr in daf-2 mutants. However, mdl-
1(0) alone did not affect Oxr; moreover, free iron levels 
appear to have little effect on aging under standard 
culture conditions [60]. More broadly, a range of studies 
suggest that oxidative damage is not a central 
determinant of aging, particularly in C. elegans [61, 62]. 
Together, these findings suggest that the intestine is one 
of several sites of action of mdl-1 on lifespan. 
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The significance of uterine tumors in C. elegans 
 
The oocyte-derived growths in the C. elegans uterus have 
been noted in previous studies and referred to as ‘tumor-
like’ growths [30], masses [24] and oocyte clusters [29]. 
Dictionary definitions of the word tumor vary, but in the 
common understanding of tumor, as in “a growth — a 
mass of tissue — that has no function” [63], these entities 
are tumors, hence our use of the term in this study. 
Arguably, C. elegans uterine tumors are both different 
and similar to mammalian cancer. It seems likely that C. 
elegans uterine tumors result from aging-associated 
overgrowth rather than mutations in oncogenes or tumor 
suppressor genes. But much of mammalian cancer, like 
worm uterine tumors, is part of the aging process. While 
it is clear that aging and cancer are associated, the 
relationship between the two remains unclear. One 
possibility is that aging results in changes in tissue 
microenvironment, e.g. due to senescent cell 
accumulation, that create more permissive conditions for 
cancer growth [64]. Aging-related tumors can occur even 
in the absence of transforming mutation, as in benign 
prostatic hyperplasia (BPH). We postulate that C. elegans 
uterine tumors, like BPH, exemplify the non-mutational-
ly driven component of aging-associated cancer.  
 
The regulatory network within which mdl-1 might 
function 
 
In mammals, Mad TFs act antagonistically to Myc TFs, 
which promote the cell cycle, growth and apoptosis, and 
reduce H ferritin expression [11, 15]. Consistent with 
this, MDL-1 inhibits germline growth and apoptosis 
(this study), and activates ftn-1 expression [14]. 
Moreover, in mammals over-expression of Myc can 
induce endomitosis and cause increased ploidy [65], 
often seen in tumors, and also in senescent cells [66, 
67], while MDL-1 antagonizes growth of uterine tumors 
formed from endomitotic oocytes (this study). Thus, 
MDL-1 in C. elegans behaves as one would expect of 
an antagonist of Myc – which is perhaps surprising 
given that C. elegans does not possess Myc. Indeed, 
Myc appears to be absent from the entire Nematode 
phylum (this study) [51].  
 
In mammals, the Tor pathway and Myc TFs work in 
concert to control protein synthesis. Myc TFs activate 
expression of translational machinery genes, including 
eIF4E, eIF4A and eIF4G, which are components of the 
eIF4F complex that promotes translational initiation [48]. 
C. elegans lacks many genes that are present in other 
animal phyla [68], which can limit its usefulness as a 
model organism. Besides Myc, this also affects the worm 
Tor pathway, which lacks several key proteins, notably 
Tsc1/Tsc2 and 4E-BP. Thus, C. elegans possesses what 
appears to be a different version of the IIS/Tor/Mad 
network of higher animals. To fully understand the worm 
network requires understanding these differences. 
 
Several interpretations have been made of the absence 
of Myc in C. elegans. First, that it reflects the relatively 
restricted C. elegans cell proliferation program [10]. 
Second, that in C. elegans the Myc role is played by a 
different bHLH TF, for example MML-1 (Myc and 
Mondo-like 1) [16]. However, arguing against this 
interpretation, MML-1 resembles Mondo rather than 
Myc, it dimerizes with MXL-2 while MDL-1 dimerizes 
with MXL-1, and deletion of mxl-2 has only minor 
phenotypic effects (abnormal migration of ray 1 
precursor cells in the male tail), and does not affect e.g. 
growth or lifespan [16]. 
 
Another possibility is that the Myc-less Mad-Max circuit 
ensures rapid growth, i.e. the nematode machinery for 
protein translation is, in the absence of DAF-16 and 
MDL-1, constitutively active. Consistent with this, 
Tsc1/Tsc2 and 4E-BP, which both antagonize growth, are 
absent from C. elegans, and most other nematodes 
(Figure 7B). Notably, in Drosophila, inhibition of growth 
resulting from reduced Tor kinase activity (e.g. by over-
expression of Tsc1 and Tsc2) can be rescued by 
overexpression of dMyc [69]. An intriguing detail is the 
presence of Tsc1/Tsc2 in several spirurid nematodes 
(Figure 7B, Table S4); notably this group includes the 
longest lived nematode species known, e.g. the maximum 
lifespan of adult Loa loa is at least 20 years [70]. Another 
possibility is that the growth inhibitory functions of 
Tsc1/Tsc2 and 4E-BP have been taken over by DAF-
16/FoxO, which is a major regulator of protein synthesis 
in C. elegans [41, 42, 45]. Thus, perhaps DAF-16 
suppresses growth in soma and germline, while MDL-1 




These results confirm that the Mad TF MDL-1 
contributes to the daf-2 longevity phenotype, and reveal a 
major role in inhibition of germline growth and reduction 
of uterine tumor development. They also suggest a role 
for intestinal MDL-1 in longevity assurance. The action 
of mdl-1 as a DAF-16 activated gene that inhibits growth 
is broadly consistent with the possibility that the effects 
of insulin/IGF-1 signaling and DAF-16 on aging are a 




C. elegans culture and strains. Worms were cultured as 
previously described [71], at 20˚C unless otherwise 
stated. Nematode strains used include N2 (wild type), 
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DR1567 daf-2(m577)III, SS104 glp-4(bn2)I, GA1200 
mdl-1(tm311)X (6X out-crossed),  GA91 daf-
16(mgDf50)I; daf-2(m577), GA1204 daf-2(m577); mdl-
1(tm311), GA1208 daf-16(mgDf50); daf-2(m577); mdl-
1(tm311), GA1226 daf-16(mgDf50); mdl-1(tm311), 
GA1230 glp-4(bn2); mdl-1(tm311), GA1604 mdl-
1(tm311); wuEx267[mdl-1 + rol-6(su1006)], GA1605 
mdl-1(tm311); wuEx268[pges-1::mdl-1 + rol-
6(su1006)]. Primers to identify mdl-1(tm311) were 
atggaacagcaactcaaccttgg and ttaaacttggaggttgattggcaag, 
and heterozygotes aatgatgtgatctcgggctcg. Primers to 
genotype daf-16(mgDf50) were as described [72]. 
 
Strain construction. Multiple mutant strains were 
generated using standard genetic and molecular 
methodologies. Strains carrying mutations on the X 
chromosome (e.g. mdl-1(tm311)) were crossed with N2 
males to generate hemizygous mutant males which were 
mated with L4 hermaphrodites of the strain carrying the 
second mutation of interest. F1 offspring were picked, 
and allowed to self-fertilise and 80 F2 were picked, 
allowed to lay eggs overnight, lysed and stored at -
20˚C. Genomic deletions were identified using PCR. In 
the presence of the temperature sensitive daf-2(m577) 
allele, F1 animals were shifted to 25˚C to select for 
dauer formation in the F2, dauers were picked and left 
to recover at 15˚C to lay eggs, the F2 were lysed and 
tested for deletions. The daf-16(mgDf50); daf-2(m577); 
mdl-1(tm311) triple mutant was constructed by mating 
daf-16; daf-2 males with daf-2; mdl-1 hermaphrodites. 
The F2 generation was cloned, lysed and offspring 
raised at 25˚C. daf-16(mgDf50) homozygotes in the F3 
were initially identified as non-dauer formers, and mdl-
1(tm311) homozygotes identified by PCR. 
 
mdl-1 transgenic lines were created by microinjection 
using PCR products and PCR fusion [73]. Primers used 
to make GA1604 were aaattgcacatgcagagacg and 
gaaagatacggaaggtgtgc. Primers used to make GA1605 
were ttgtctattggtatggctgc; ggttgagttgctgttccattacaaggaa 
tatccgcatctg; gcgctaccaataaggctaag; aatggaacagcaactc 
aacc; gaaagatacggaaggtgtgc; and tttacaacacgatccacacg. 
 
Staining protocols. To quantify germ cell number, 
nuclei were stained using DNA-binding dye 4',6-
diamidino-2-phenylindole (DAPI). Animals were fixed 
in methanol, washed with M9 buffer and incubated in 
the dark in a 500ng/μl DAPI solution for 30 min. 
Thereafter they were washed again in M9 buffer. To 
quantify the number of apoptotic cells in living animals, 
nematodes were stained with SYTO 12 Green 
Fluorescent Nucleic Acid Stain (Molecular Probes). The 
animals were incubated in the dark in a 33μM SYTO 12 
solution for 4 hr, and then placed on an OP50 lawn for 1 
hr.  
Quantitative RT-PCR and chromatin immuno-
precipitation PCR (ChIP-PCR). RT-PCR and ChIP-PCR 
were performed largely as previously described [9, 74]. 
Primers for RT-PCR amplification from mdl-1 mRNA 
were cccgtttgcgtgtcattgt and atggattgtgagagtgttgagaat. 
Primers for ChIP-PCR of an mdl-1 promoter region 
(Figure 1A) were ccccctcgttttctccatgt and 
gccgctcgctccaatg. 
 
Microscopy. Freshly prepared agar pads were created 
by dropping 35µl of 2% agarose onto a glass slide. 
Worms were anaesthesised using 5µl 0.2% levamisole. 
Nomarski microscopy was performed on a Zeiss 
Axioskop2 plus microscope with a Hamamatsu ORCA-
ER digital camera C4742-95. Images were acquired 
using Volocity 5.5 software, with 10x eyepieces and a 
40x objective lens. For body size measurements, worms 
were synchronized and hatched overnight in M9 buffer. 
The next day, ~30 worms per strain were imaged, and 
the remainder cultured on OP50 and thereafter imaged 
consecutively for 6 days. Volocity 5.5 was used to 
quantify the length of the worm from head to tail and 
the width across the pharyngeal-intestinal valve region. 
 
Uterine tumor scoring system. Uterine status was scored 
from 1 to 5, where scores of 3-5 indicates the presence 
of a tumor. Class 1 denotes a normal, youthful uterus 
containing fertilized eggs and/or unfertilized oocytes of 
normal appearance. Class 2 denotes a uterus whose 
contents appear somewhat abnormal, but without a clear 
increase in size. Class 3 denotes a uterus containing a 
small tumor. Class 4 denotes a uterus containing a 
medium sized tumor, that does not fill the body cavity 
in the mid-body region.  Class 5 denotes a uterus where 
the tumor is large, and fill the entire body cavity in the 
mid-body region, and even causes distension of the 
body wall. For the scoring, the tumor images was 
randomised, and the scoring was performed blinded by 
3 different scorers. The non-parametric Wilcoxon test 
was used to compare tumor classes between worm 
strains and within the same strain on day 1 and day 4. 
The analysis was performed using the statistical 
programme JMP 9 (SAS Institute Inc.)  
 
Fertility measurements. Brood sizes were assayed as 
previously described [22]. Briefly, 10-12 L4 
hermaphrodites, raised at 20˚C were cloned on 
individual plates, shifted to 25˚C and transferred daily 
for 7 days. Plates were incubated at 20˚C for 24 hr to 
allow offspring to hatch and then larvae, unfertilized 
oocytes and dead eggs were scored.  
 
Yolk level measurements. For each test sample, 50 
hermaphrodites at day 1 and 4 of adulthood were 
transferred into an Eppendorf tube filled with 1 ml M9 
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buffer. Worms were spun at 800 rpm for 2 min and 
supernatant removed, leaving 25 µl. Then 25 µl of 2x 
Laemmli buffer (Sigma) was added, and samples 
incubated at 70˚C for 15 min, vortexed every other 
minute and then shifted to 95˚C for 5 min. Lysates were 
centrifuged at 13,000 rpm at 4˚C for 15 min. 20 µl of 
each sample was loaded onto a Criterion XT Tris-
Acetate gel. The gel was run at 200V in SDS-PAGE 
chamber with 1x 3-(N-morpholino) propanesulfonic 
acid (MOPS) buffer for 45 min. The gel was fixed in 
methanol, acetic acid and ultrapure water in ratio of 
50:10:40 for 30 min. The fixing solution was then 
discarded and replaced with Coomassie fixation 
solution (50:3:40:10 methanol: Coomassie stock 
solution: ultrapure water: acetic acid). 12.0 g of Brilliant 
Blue R-250, 300 ml methanol and 60ml acetic acid were 
used to prepare Coomassie stock solution. The gel was 
incubated overnight in destaining solution (45:10:45 
methanol: acetic acid: ultrapure water). Protein bands 
on the gel were visualised by a Image Quant GE 
Healthcare scanner system connected to a computer, 
and analysed by ImageQuant software with which 
densitometry was performed. Each experiment was 
done in triplicate. 
 
Lifespan measurements. These were conducted as 
previously described [22]. Briefly, 5 plates per 
condition were seeded with OP50 2 days before the start 
of the experiment. 10 μM FUdR was topically applied 
before beginning the trial. Animals were raised at 20˚C, 
or for assays including glp-4(bn2) mutants, animals 
were raised at 15˚C and switched to 25˚C at L4 stage. 
All animals were transferred to fresh plates on day 5 
and 10. Deaths were scored and losses due to causes 
other than death were censored. Lifespan data were 
deposited in SurvCurv [75] <IDs filled in proof>. 
 
Dauer formation measurement.  Dauer formation was 
assessed at 22.9˚C as previously described [22]. Briefly, 
12 L4s were picked and raised to adulthood at 20˚C for 
2 days. These gravid adults were then placed on 35mm 
plates to lay eggs for 6 hrs at the test temperature, after 
which the adults were removed and the larvae were 
allowed to develop at the test temperature. Dauers and 
normal larvae were scored 72 hr after the midpoint of 
the egg lay and the percentage dauer formation was 
calculated by dividing the number of dauer larvae by 
the total number of offspring. 
 
Oxidative stress resistance. 1 day old adults were tested 
for resistance to 7.5 mM tert-butylhydroperoxide (t-
BOOH) as previously described [33]. Briefly, L4 
animals were picked from mixed stage plates raised at 
20˚C, then shifted to 25˚C overnight. NGM agar was 
supplemented with 7.5 mM t-BOOH and the plates 
were left to dry overnight. The next day, each plate was 
supplemented with a blob of densely grown OP50, and 
15 young adults were added per plate. The trial was 
conducted at 25˚C and animals were scored every 2 to 3 
hr until the last animal had perished. 
 
Bioinformatics. Myc, Tsc1, Tsc2 and 4E-BP orthologs 
were sought by local alignment searches of the 4 
protein sequences to the gene models in Mus musculus 
using BLASTP searches. Since not all genomes were 
available in WormBase, orthologs for the parasitic 
helminths (B. xylophilus, E. granulosus, E. 
multilocularis, T. solium, H. microstoma, S. mansoni 
and S. japonicum) were derived from GeneDB. 
Orthologs for G. pallida, H. contortus, O. volvulus, S. 
ratti and T. muris were sought using the data available 
on the Sanger Institute Resources. Orthologs to T. 
muris were sought by local alignment searches of the 4 
genes to contigs, using a “protein versus translated 
DNA” a TBLASTN search. Finally, orthologs of P. 
pacificus were sought among the gene predictions 
available from www.pristionchus.org. Multiple 
sequence alignments of the Tsc1/2 protein sequences 
were done using MUSCLE [76]. All trees were 
constructed and visualised as previously described 
[74].  
 
Statistical analysis. Lifespans were analysed using the 
Cox Proportional Hazard method with the Efron 
approximation for ties of the survival package in R. The 
logistic mortality models were fitted to the lifespan data 
and parameter difference tested using the Survomatic R 
package. The body sizes were analysed using a linear 
regression model taking into account the trial as random 
factor in R. The Wilcoxon Mann test was used for 
tumors and the brood sizes were compared using a 




We wish to thank Mikhail Nikiforov for useful 
discussion, and Filipe Cabreiro for comments on the 
manuscript. Some nematode strains used in this work 
were provided by the Caenorhabditis Genetics Center, 
which is funded by the National Institutes of Health 
National Center for Research Resources and the 
National Bioresource Project of Japan. This work was 
supported by the Wellcome Trust (Strategic Award), 
EMBL and the European Union (IDEAL). 
 
Conflicts of Interest Statement 
 
The authors of this manuscript have no conflict of 
interest to declare. 
  





elegans mutant  that  lives  twice  as  long  as wild  type.  Nature. 
1993; 366:461‐464. 




HA  and  Ruvkun  G.  The  Fork  head  transcription  factor  DAF‐16 






Ahringer  J,  Li H and Kenyon CJ. Genes  that act downstream of 
DAF‐16  to  influence  the  lifespan  of  C.  elegans.  Nature.  2003; 
424:277‐284. 
7. McElwee  JJ,  Schuster  E,  Blanc  E,  Thomas  JH  and  Gems  D. 
Shared  transcriptional  signature  in C. elegans dauer  larvae and 
long‐lived  daf‐2  mutants  implicates  detoxification  system  in 
longevity assurance. J Biol Chem. 2004; 279:44533‐44543. 
8.  Partridge  L,  Alic  N,  Bjedov  I  and  Piper  MD.  Ageing  in 
Drosophila:  the  role  of  the  insulin/Igf  and  TOR  signalling 
network. Exp Gerontol. 2011; 46:376‐381. 
9. Schuster E, McElwee JJ, Tullet JMA, Doonan R, Matthijssens F, 
Reece‐Hoyes  JS, Hope  IA, Vanfleteren  JR, Thornton  J and Gems 
D. DamID  in  C.  elegans  reveals  longevity‐associated  targets  of 
DAF‐16/FoxO. Mol Syst Biol. 2010; 6:399. 
10. Yuan  J, Tirabassi RS, Bush AB and Cole MD. The C. elegans 
MDL‐1  and  MXL‐1  proteins  can  functionally  substitute  for 
vertebrate MAD and MAX. Oncogene. 1998; 17:1109‐1118. 
11.  Grandori  C,  Cowley  SM,  James  LP  and  Eisenman  RN.  The 
Myc/Max/Mad  network  and  the  transcriptional  control  of  cell 
behavior. Ann Rev Cell Dev. 2000; 16:653‐699. 
12.  Gems  D  and  Partridge  L.  Genetics  of  longevity  in  model 
organisms:  Debates  and  paradigm  shifts.  Annual  Review  of 
Physiology. 2013; 75:621‐644. 
13. Delpuech O, Griffiths B, East P, Essafi A, Lam EW, Burgering 
B,  Downward  J  and  Schulze  A.  Induction  of Mxi1‐SR  alpha  by 
FOXO3a  contributes  to  repression  of  Myc‐dependent  gene 
expression. Mol Cell Biol. 2007; 27:4917‐4930. 
14. Ackerman D and Gems D. Insulin/IGF‐1 and hypoxia signaling 
act  in  concert  to  regulate  iron homeostasis  in C. elegans. PLoS 
Genet. 2012; 8:e1002498. 
15.  Le  N  and  Richardson  D.  The  role  of  iron  in  cell  cycle 
progression  and  the  proliferation  of  neoplastic  cells.  Biochim 
Biophys Acta. 2002; 1603:31–46. 
16.  Pickett  CL,  Breen  KT  and  Ayer  DE.  A  C.  elegans Myc‐like 
networks  cooperates  with  semaphorin  and  Wnt  signaling 
pathways to control cell migration. Dev Biol. 2007; 310:226‐239. 
17. Grove CA, De Masi F, Barrasa MI, Newburger DE, Alkema MJ, 
Bulyk ML  and Walhout  AJ.  A multiparameter  network  reveals 
extensive  divergence  between  C.  elegans  bHLH  transcription 
factors. Cell. 2009; 138:314‐327. 
18. Pinkston JM, Garigan D, Hansen M and Kenyon C. Mutations 
that  increase  the  life  span of C.  elegans  inhibit  tumor  growth. 
Science. 2006; 313:971‐975. 
19. Pinkston‐Gosse J and Kenyon C. DAF‐16/FOXO targets genes 
that  regulate  tumor  growth  in  Caenorhabditis  elegans.  Nat 
Genet. 2007; 39:1403‐1409. 
20.  Gems  D  and  Riddle  DL.  Defining  wild‐type  life  span  in 







mutation  affect  larval  arrest,  adult behavior,  reproduction  and 
longevity  in  Caenorhabditis  elegans.  Genetics.  1998;  150:129‐
155. 
23.  Jud  M,  Razelun  J,  Bickel  J,  Czerwinski  M  and  Schisa  JA. 
Conservation  of  large  foci  formation  in  arrested  oocytes  of 
Caenorhabditis nematodes. Dev Genes Evol. 2007; 217:221‐226. 
24.  Hughes  SE,  Huang  C  and  Kornfeld  K.  Identification  of 
mutations  that  delay  somatic  or  reproductive  aging  of 
Caenorhabditis elegans. Genetics. 2011; 189:341‐356. 
25.  Gumienny  TL,  Lambie  E,  Hartwieg  E,  Horvitz  HR  and 
Hengartner MO. Genetic  control  of  programmed  cell  death  in 
the  Caenorhabditis  elegans  hermaphrodite  germline. 
Development. 1999; 126:1011‐1022. 
26.  Jaramillo‐Lambert  A,  Ellefson  M,  Villeneuve  AM  and 
Engebrecht  J.  Differential  timing  of  S  phases,  X  chromosome 
replication,  and meiotic  prophase  in  the  C.  elegans  germ  line. 
Dev Biol. 2007; 308:206‐221. 
27.  Wolke  U,  Jezuit  EA  and  Priess  JR.  Actin‐dependent 











and  Melov  S.  Dramatic  age‐related  changes  in  nuclear  and 
genome copy number  in the nematode Caenorhabditis elegans. 
Aging Cell. 2007; 6:179‐188. 
31.  McGee  MD,  Day  N,  Graham  J  and  Melov  S.  cep‐1/p53‐
dependent dysplastic pathology of  the aging C. elegans gonad. 
Aging. 2012; 4:256‐269. 
32.  Qi  W,  Huang  X,  Neumann‐Haefelin  E,  Schulze  E  and 
Baumeister R. Cell‐nonautonomous signaling of FOXO/DAF‐16 to 
the  stem  cells  of  Caenorhabditis  elegans.  PLoS  Genet.  2012; 
8:e1002836. 
33.  Tullet  JM,  Hertweck M,  An  JH,  Baker  J,  Hwang  JY,  Liu  S, 
Oliveira RP, Baumeister R and Blackwell TK. Direct  inhibition of 
the  longevity‐promoting factor SKN‐1 by  insulin‐like signaling  in 
C. elegans. Cell. 2008; 132:1025‐1038. 
34.  Johnson  T, Wu D,  Tedesco  P, Dames  S  and Vaupel  J. Age‐
specific  demographic  profiles  of  longevity  mutants  in 
Caenorhabditis  elegans  show  segmental  effects.  J  Gerontol  A 
Biol Sci Med Sci. 2001; 56:B331‐B339. 
35.  Vanfleteren  JR,  De  Vreese  A  and  Braeckman  BP.  Two‐
parameter  logistic and Weibull equations provide better  fits  to 
survival  data  from  isogenic  populations  of  Caenorhabditis 
  
www.impactaging.com                    113                                    AGING, February 2014, Vol. 6 No.2
elegans  in  axenic  culture  than  does  the  Gompertz  model.  J 
Gerontol A Biol Sci Med Sci. 1998; 53:B393‐B403. 




A  simple method  for maintaining  large,  aging  populations    of 
Caenorhabditis elegans. Mech Ageing Dev. 1980; 12:137‐150. 






C.  elegans  DAF‐16  in  the  regulation  of  lifespan.  Cell.  2003; 
115:489‐502. 
41. Depuydt G,  Xie  F,  Petyuk  VA,  Shanmugam N,  Smolders  A, 
Dhondt  I, Brewer HM, Camp DG, Smith RD and Braeckman BP. 
Reduced  insulin/IGF‐1  signaling  and  dietary  restriction  inhibit 
translation but preserve muscle mass in Caenorhabditis elegans. 
Mol Cell Proteomics. 2013. 
42.  Stout  GJ,  Stigter  EC,  Essers  PB,  Mulder  KW,  Kolkman  A, 
Snijders  DS,  van  den  Broek  NJ,  Betist  MC,  Korswagen  HC, 
Macinnes  AW  and  Brenkman  AB.  Insulin/IGF‐1‐mediated 






Sakano  Y,  Paupard  M,  Hall  D  and  Driscoll  M.  Stochastic  and 
genetic  factors  influence  tissue‐specific  decline  in  ageing  C. 
elegans. Nature. 2002; 419:808‐814. 
45. Depina A, Iser W, Park S, Maudsley S, Wilson M and Wolkow 
C.  Regulation  of  Caenorhabditis  elegans  vitellogenesis  by DAF‐
2/IIS  through  separable  transcriptional  and  posttranscriptional 
mechanisms. BMC Physiol. 2011; 11:11. 
46.  Kimble  J,  Sharrock,  WJ.  Tissue‐specific  synthesis  of  yolk 
proteins in Caenorhabditis elegans. Dev Biol. 1983; 96:189‐196. 
47. Aamodt EJ, Chung MA and McGhee JD. Spatial control of gut‐
specific  gene  expression  during  Caenorhabditis  elegans 
development. Science. 1991; 252:579‐582. 
48. Lin C‐J, Malina A and Pelletier J. c‐Myc and eIF4F consistute a 
feedforward  loop  that  regulates  cell  growth:  implications  for 
anticancer therapy. Cancer Res. 2009; 69:7491‐7494. 
49. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL 
and  Kockel  L.  With  TOR,  less  is  more:  a  key  role  for  the 
conserved  nutrient‐sensing  TOR  pathway  in  aging.  Cell Metab. 
2010; 11:453‐465. 
50. Syntichaki P, Troulinaki K and Tavernarakis N. eIF4E function 








53.  Blagosklonny MV.  Cell  cycle  arrest  is  not  yet  senescence, 





55.  Finch  CE,  Pike  MC  and  Witten  M.  Slow  mortality  rate 
accelerations during aging  in some animals approximate that of 
humans. Science. 1990; 249:902‐905. 
56.  Gems  D. What  is  an  anti‐aging  treatment?  Exp  Gerontol. 
2014 (In press). 
57. Blagosklonny MV. Aging and immortality: quasi‐programmed 
senescence  and  its  pharmacologic  inhibition.  Cell  Cycle.  2006; 
5:2087‐2102. 
58.  Blagosklonny  MV.  Paradoxes  of  aging.  Cell  Cycle.  2007; 
6:2997‐3003. 
59.  Gems  D  and  de  la  Guardia  Y.  Alternative  perspectives  on 
aging  in  C.  elegans:  reactive  oxygen  species  or  hyperfunction? 
Antioxid Redox Signal. 2013; 19:321‐329. 
60. Valentini S, Cabreiro F, Ackerman D, Alam MM, Kunze MBA, 
Kay CWM and Gems D. Manipulation of  in  vivo  iron  levels  can 
alter  resistance  to  oxidative  stress without  affecting  ageing  in 
the nematode C. elegans. Mech Ageing Dev. 2012; 133:282‐290. 
61. Van Raamsdonk  JM and Hekimi S. Reactive oxygen  species 
and  aging  in  Caenorhabditis  elegans:  causal  or  casual 
relationship? Antioxid Redox Signal. 2010; 13:1911‐1953. 
62. Gems D and Doonan R. Antioxidant defense and aging  in C. 
elegans:  is  the  oxidative  damage  theory  of  aging wrong?  Cell 
Cycle. 2009; 8:1681‐1687. 
63. Vocabulary.com. (2013). tumor. 
64.  Campisi  J.  Senescent  cells,  tumor  suppression,  and 






signaling  pathways  in  human  and mouse  cells.  EMBO  J.  2002; 
21:4338‐4348. 
67. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W and 
Jansen‐Durr  P.  Replicative  senescence  of  human  endothelial 
cells in vitro involves G1 arrest, polyploidization and senescence‐
associated apoptosis. Exp Gerontol. 2001; 36:1327‐1347. 
68.  Coghlan  A.  (2005).  Nematode  genome  evolution.  In: 
Community TCeR, ed. WormBook. 
69. Gallant P. Myc/Max/Mad  in  invertebrates:  the evolution of 
the Max network. Curr Top Microbiol  Immunol 2006; 302:235‐
253. 





M,  Iser W, Wolkow  C,  Krause M  and  Hanover  J.  Dynamic  O‐
GlcNAc  cycling  at  promoters  of  Caenorhabditis  elegans  genes 
regulating longevity, stress, and immunity. Proc Natl Acad Sci U S 
A. 2010; 107:7413‐7418. 
73.  Hobert  O.  PCR  fusion‐based  approach  to  create  reporter 
gene constructs for expression analysis in transgenic C. elegans. 
Biotechniques. 2002; 32(4):728‐730. 
74.  Tullet  JMA,  Araiz  C,  Sanders  MJ,  Au  C,  Benedetto  A, 
Papatheodorou  I,  Clark  E,  Schmeisser  K,  Jones D,  Schuster  EF, 
Thornton  JM  and  Gems  D.  DAF‐16/FoxO  directly  regulates  an 
atypical  AMP‐activated  protein  kinase  gamma  isoform  to 
  
www.impactaging.com                     114                                   AGING, February 2014, Vol. 6 No.2
mediate  the  effects  of  insulin/IGF‐1  signaling  on  aging  in  C. 
elegans. PLoS Genet. 2013; In press. 





































































































Table  S1.  Effect  of mdl‐1  on  life  span  in  C.  elegans.  The  trials were  performed  at  25°C 
without  FUdR.  Genotype:  N2  wildtype,  GA1200  mdl‐1(tm311),  DR1567  daf‐2  (m577), 
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